Pulmonary Arterial Hypertension Market Scope And Analysis

  • Report Code : TIPRE00005221
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 174
Buy Now

Pulmonary Arterial Hypertension Market Analysis, Scope, and Growth by 2028

Buy Now

Pulmonary Arterial Hypertension Market Report Pulmonary Arterial Hypertension Market Size and Share Pulmonary Arterial Hypertension Market Scope and Analysis

Pulmonary Arterial Hypertension Market Report Scope

Report Attribute Details
Market size in 2021 US$ 7.37 Billion
Market Size by 2028 US$ 10.89 Billion
Global CAGR (2021 - 2028) 5.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Drugs
  • Endothelin Receptor Antagonists
  • Prostacyclin and Prostacyclin Analogs
  • sGC Stimulators
  • pde-5 Dipsticks
By Type
  • Branded and Generics
By Route of Administration
  • Oral
  • Intravenous/Subcutaneous
  • Inhalational
By Distribution Channel
  • Hospital Pharmacies and Clinics
  • Online Pharmacies
  • Retail Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Johnson Johnson
  • Gilead Sciences Inc
  • United Therapeutics Corp
  • Bayer AG
  • Aerami Therapeutics Holdings Inc
  • Novartis AG
  • GSK Plc
  • Teva Pharmaceutical Industries Ltd
  • Lupin Ltd

    • Company Profiles

    • Johnson & Johnson                   
    • Gilead Sciences Inc                  
    • United Therapeutics Corp          
    • Bayer AG
    • Aerami Therapeutics Holdings Inc                                                       
    • Novartis AG                            
    • GSK Plc                                                                               
    • Lupin Ltd                                
    • Pfizer Inc
    • Teva Pharmaceutical Industries Ltd.